MX2021001845A - Un medicamento combinado que comprende fenilefrina y paracetamol. - Google Patents
Un medicamento combinado que comprende fenilefrina y paracetamol.Info
- Publication number
- MX2021001845A MX2021001845A MX2021001845A MX2021001845A MX2021001845A MX 2021001845 A MX2021001845 A MX 2021001845A MX 2021001845 A MX2021001845 A MX 2021001845A MX 2021001845 A MX2021001845 A MX 2021001845A MX 2021001845 A MX2021001845 A MX 2021001845A
- Authority
- MX
- Mexico
- Prior art keywords
- phenylephrine
- paracetamol
- pharmaceutically acceptable
- combination
- equivalent amount
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 6
- 229960005489 paracetamol Drugs 0.000 title abstract 6
- 229960001802 phenylephrine Drugs 0.000 title abstract 6
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 title abstract 6
- 239000003814 drug Substances 0.000 title abstract 5
- 229940079593 drug Drugs 0.000 title 1
- 229960003733 phenylephrine hydrochloride Drugs 0.000 abstract 5
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 abstract 5
- 208000027744 congestion Diseases 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
El uso del hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina) y paracetamol en la producción de un medicamento combinado para el tratamiento de la congestión de las mucosas de las vías respiratorias superiores, medicamento que comprende la combinación de tales sustancias con excipientes, caracterizado porque el medicamento contiene el hidrocloruro de fenilefrina (o la cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina) y paracetamol en las proporciones adecuadas para, y el medicamento es para, suministrar le a un adulto: a 4 mg - 7,5 mg de hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina), en combinación con 950 mg - 1000 mg de paracetamol; o b 5 mg - 7,5 mg de hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina), en combinación con 600 mg - 700 mg de paracetamol; c 6 mg - 8 mg de hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina), en combinación con 500 mg - 550 mg de paracetamol.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ60665913 | 2013-02-04 | ||
| NZ61013213 | 2013-05-02 | ||
| NZ61391813 | 2013-08-02 | ||
| NZ61802713 | 2013-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021001845A true MX2021001845A (es) | 2021-05-13 |
Family
ID=51262632
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015009681A MX381450B (es) | 2013-02-04 | 2014-01-07 | Un medicamento combinado que comprende fenilefrina y paracetamol |
| MX2021001845A MX2021001845A (es) | 2013-02-04 | 2015-07-27 | Un medicamento combinado que comprende fenilefrina y paracetamol. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015009681A MX381450B (es) | 2013-02-04 | 2014-01-07 | Un medicamento combinado que comprende fenilefrina y paracetamol |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP2830605B8 (es) |
| CN (2) | CN107811999A (es) |
| AP (1) | AP2015008704A0 (es) |
| BR (1) | BR112015015938A2 (es) |
| CA (1) | CA2893836C (es) |
| EC (1) | ECSP15033649A (es) |
| LU (1) | LU92526B1 (es) |
| MX (2) | MX381450B (es) |
| MY (1) | MY198201A (es) |
| PE (1) | PE20151282A1 (es) |
| PH (2) | PH12021550907A1 (es) |
| PL (1) | PL2830605T3 (es) |
| RS (1) | RS64807B1 (es) |
| SG (1) | SG11201504389QA (es) |
| TW (1) | TW201434464A (es) |
| WO (1) | WO2014120021A1 (es) |
| ZA (1) | ZA201504080B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
| US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| HUE053181T2 (hu) | 2015-05-21 | 2021-06-28 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Gyógyszerészeti készítmény megnövelt oldékonysággal és stabilitással |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260600A (en) * | 1979-10-22 | 1981-04-07 | Ronald Valle | Method of treating depression |
| US20040162273A1 (en) * | 2003-01-23 | 2004-08-19 | The Procter & Gamble Company | Powder pharmaceutical compositions |
| GB2443793B (en) * | 2006-04-05 | 2010-12-01 | Reckitt Benckiser Healthcare | Product, method of manufacture and use |
| US20070254027A1 (en) * | 2006-04-28 | 2007-11-01 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| US20100288665A1 (en) | 2007-07-23 | 2010-11-18 | Kingsway Pharmaceuticals Inc. | Therapeutic formulations for the treatment of cold and flu-like symptoms |
| CA2716923A1 (en) * | 2008-03-17 | 2009-09-24 | The Procter & Gamble Company | User-customizable dosing system |
| US8518439B2 (en) * | 2008-12-03 | 2013-08-27 | Novartis Ag | Liquid therapeutic composition |
| US20110104272A1 (en) * | 2009-11-05 | 2011-05-05 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
| WO2012090218A1 (en) * | 2010-12-30 | 2012-07-05 | Zota Health Care Ltd | Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases |
-
2014
- 2014-01-07 AP AP2015008704A patent/AP2015008704A0/xx unknown
- 2014-01-07 PE PE2015001231A patent/PE20151282A1/es unknown
- 2014-01-07 MY MYPI2015702023A patent/MY198201A/en unknown
- 2014-01-07 RS RS20230953A patent/RS64807B1/sr unknown
- 2014-01-07 CN CN201711276478.7A patent/CN107811999A/zh active Pending
- 2014-01-07 EP EP14746905.0A patent/EP2830605B8/en active Active
- 2014-01-07 CN CN201480003659.0A patent/CN104936585B/zh active Active
- 2014-01-07 LU LU92526A patent/LU92526B1/xx active
- 2014-01-07 SG SG11201504389QA patent/SG11201504389QA/en unknown
- 2014-01-07 BR BR112015015938A patent/BR112015015938A2/pt not_active Application Discontinuation
- 2014-01-07 MX MX2015009681A patent/MX381450B/es unknown
- 2014-01-07 WO PCT/NZ2014/000001 patent/WO2014120021A1/en not_active Ceased
- 2014-01-07 PH PH1/2021/550907A patent/PH12021550907A1/en unknown
- 2014-01-07 PL PL14746905.0T patent/PL2830605T3/pl unknown
- 2014-01-07 CA CA2893836A patent/CA2893836C/en not_active Expired - Fee Related
- 2014-01-29 TW TW103103365A patent/TW201434464A/zh not_active IP Right Cessation
-
2015
- 2015-06-05 ZA ZA2015/04080A patent/ZA201504080B/en unknown
- 2015-06-05 PH PH12015501294A patent/PH12015501294A1/en unknown
- 2015-07-27 MX MX2021001845A patent/MX2021001845A/es unknown
- 2015-08-03 EC ECIEPI201533649A patent/ECSP15033649A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2830605A1 (en) | 2015-02-04 |
| AP2015008704A0 (en) | 2015-09-30 |
| PE20151282A1 (es) | 2015-10-04 |
| TWI514998B (es) | 2016-01-01 |
| EP2830605B8 (en) | 2023-11-08 |
| ECSP15033649A (es) | 2015-11-30 |
| PH12015501294A1 (en) | 2015-08-24 |
| CN104936585B (zh) | 2017-11-14 |
| CA2893836A1 (en) | 2014-08-07 |
| ZA201504080B (en) | 2016-04-28 |
| PL2830605T3 (pl) | 2024-02-19 |
| SG11201504389QA (en) | 2015-08-28 |
| CA2893836C (en) | 2017-05-02 |
| CN107811999A (zh) | 2018-03-20 |
| TW201434464A (zh) | 2014-09-16 |
| MX2015009681A (es) | 2016-07-11 |
| MX381450B (es) | 2025-03-12 |
| EP2830605A4 (en) | 2015-02-04 |
| BR112015015938A2 (pt) | 2017-07-11 |
| WO2014120021A1 (en) | 2014-08-07 |
| PH12021550907A1 (en) | 2023-07-17 |
| MY198201A (en) | 2023-08-10 |
| RS64807B1 (sr) | 2023-12-29 |
| CN104936585A (zh) | 2015-09-23 |
| EP2830605B1 (en) | 2023-09-27 |
| LU92526B1 (fr) | 2014-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015009772A (es) | Moduladores de receptores nmda de espiro-lactama y sus usos. | |
| MX2017010304A (es) | Composiciones farmaceuticas que comprenden meloxicam. | |
| CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
| MX390627B (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
| CO2019000945A2 (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos | |
| MX2016010179A (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| EA201491479A1 (ru) | Производные лупановых тритерпеноидов и их фармацевтическое применение | |
| CO2019000943A2 (es) | Moduladores del receptor nmda espiro-lactam y uso de los mismos | |
| MX2019001322A (es) | Moduladores del receptor nmda spiro-lactam y bis-spiro-lactam y uso de los mismos. | |
| ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
| EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
| MX2021001845A (es) | Un medicamento combinado que comprende fenilefrina y paracetamol. | |
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| EA201991265A1 (ru) | Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат | |
| UY31790A (es) | Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona | |
| UY35890A (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
| CO2018013792A2 (es) | Regímenes de dosificación de vortioxetina para el rápido inicio del efecto antidepresivo | |
| AR095149A1 (es) | Medicamento que comprende fenilefrina y paracetamol | |
| ECSP17008187A (es) | Formas de dosificación farmacéutica | |
| UY36474A (es) | Método para producir liposomas que contienen un ingrediente farmacéutico activo | |
| CR20150363A (es) | Combinación de un medicamento que comprende fenilefrina y paracetamol | |
| CO2018010142A2 (es) | Proceso de preparación de fórmulas solidas de mesalazina | |
| MX372644B (es) | Una combinacion de unidades de dosificacion para su uso en el tratamiento del parto prematuro. | |
| AR105087A1 (es) | Métodos para el tratamiento de mujeres con trastorno de deseo sexual hipoactivo (hsdd) con el tratamiento de combinación bupropión y trazodona | |
| CO2019008347A2 (es) | Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla |